Bravoxin 10 suspension for injection for cattle and sheep
Bravoxin 10 suspension for injection for cattle and sheep
Authorised
- Clostridium novyi, type D, toxoid
- Clostridium sordellii, toxoid
- Tetanus toxoid adsorbed
- Clostridium septicum, toxoid
- Clostridium novyi, toxoid
- Clostridium chauvoei, Inactivated
- Clostridium perfringens, type D, epsilon toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium perfringens, type B, beta toxoid
- Clostridium perfringens, type A, alpha toxoid
Product identification
Medicine name:
Bravoxin 10 suspension for injection for cattle and sheep
BRAVOXIN 10
Active substance:
- Clostridium novyi, type D, toxoid
- Clostridium sordellii, toxoid
- Tetanus toxoid adsorbed
- Clostridium septicum, toxoid
- Clostridium novyi, toxoid
- Clostridium chauvoei, Inactivated
- Clostridium perfringens, type D, epsilon toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium perfringens, type B, beta toxoid
- Clostridium perfringens, type A, alpha toxoid
Target species:
-
Cattle
-
Sheep
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Clostridium novyi, type D, toxoid17.40unit(s)1.00millilitre(s)
-
Clostridium sordellii, toxoid4.40international unit(s)1.00millilitre(s)
-
Tetanus toxoid adsorbed4.90international unit(s)1.00millilitre(s)
-
Clostridium septicum, toxoid4.60international unit(s)1.00millilitre(s)
-
Clostridium novyi, toxoid3.80international unit(s)1.00millilitre(s)
-
Clostridium chauvoei, Inactivated90.00percentage protection1.00millilitre(s)
-
Clostridium perfringens, type D, epsilon toxoid5.30international unit(s)1.00millilitre(s)
-
Clostridium perfringens, type C, beta toxoid18.20international unit(s)1.00millilitre(s)
-
Clostridium perfringens, type B, beta toxoid18.20international unit(s)1.00millilitre(s)
-
Clostridium perfringens, type A, alpha toxoid0.50enzyme-linked immunosorbent assay unit1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cattle
-
Milk0day
-
Meat and offal0day
-
- Sheep
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AB01
- QI04AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Package description:
- (ID1): 1 Box with 1 Bottle (Low Density PolyEthylene) with 20 millilitre(s) (20 millilitre(s))
- (ID2): 1 Box with 1 Bottle (Low Density PolyEthylene) with 50 millilitre(s) (50 millilitre(s))
- (ID3): 1 Box with 1 Bottle (Low Density PolyEthylene) with 100 millilitre(s) (100 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- MSD Animal Health S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
- MSD Animal Health UK Limited
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- Ministry Of Health
Authorisation number:
- 104043
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0279/001
Concerned member states:
-
Belgium
-
France
-
Ireland
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 14/05/2022
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
How useful was this page?: